Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cell Source Inc
CLCSCurrent price
0.7 USD
0 USD (0.00%)
Last closed
0.7 USD
Company
cell-source.com
ISIN
US15114L1044
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCQB
Capitalization
19 712 474 USD
Yield for 12 month
+16.67 %
1Y
3Y
5Y
10Y
15Y
CLCS
Cell Source, Inc., a biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance. Its lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. The company's Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease; other non-malignant organ diseases through organ transplantation; and various cancers and non-malignant diseases. Cell Source, Inc. is headquartered in New York, New York. Address: 57 West 57th Street, New York, NY, United States, 10019
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures CLCS
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-661.78 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
–
Revenue TTM
–
Book Value
-0.41 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.15 USD
Diluted Eps TTM
-0.15 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CLCS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CLCS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CLCS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-6.4479
Price Book MRQ
–
Financials CLCS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CLCS
For 52 weeks
0.0002 USD
0.75 USD
50 Day MA
0.36 USD
Shares Short Prior Month
–
200 Day MA
0.25 USD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart